buserelin


Also found in: Wikipedia.

buserelin

A long-acting GnRH-gonadotropin-releasing hormone analogue, which causes permanent pitutary stimulation and downregulates the pituitary-gonadal axis, blocking testosterone production in the testes; it has been used to treat metastatic prostate and breast cancer, to create pseudomenopause to reduce the size and number of endometriotic lesions and fibroids. It has also been used for hirsutism, to induced ovulation and for in vitro fertilisation.

buserelin

Suprefact® Infertility A long-acting gonadotropin-releasing hormone analogue which downregulates the pituitary-gonadal axis, block testosterone production in the testes; it has been used to treat metastatic prostate CA. See Disease flare.

buserelin

A gonadothropin-releasing hormone drug used in the treatment of ENDOMETRIOSIS and INFERTILITY. Brand names are Suprecur and Suprefact.
Mentioned in ?
References in periodicals archive ?
The female was administered with an intraperitoneal injection, using a synthetic analog of the gonadotropin-releasing hormone (GnRH, buserelin acetate (Pyr-His-Trp-Ser-Tyr-DSer- (But) -Leu-Arg-Pro).
Effects of short-course buserelin therapy on adenomyosis.
The main GnRH analogs commercially used for ovulation induction in pigs are triptorelin and buserelin, and the differences between the two are mainly related to route and time of administration according to the protocol of synchronization (KNOX et al., 2011; DRIANCOURT et al., 2013; KIRKWOOD & KAUFFOLD, 2015).
Comparison of estrus synchronization programmes in dairy cattle using oestradiol benzoate, short-acting progesterone and cloprostenol, or buserelin and cloprostenol.
Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 2000 Mar; 15(3):526-531.
The Buserelin injection hurts the most and leaves my skin red and itchy.
Synchronization of estrus and fertility in beef cattle with two injections of buserelin and prostaglandin.
Long protocol of down regulation of ovaries was achieved by sub cutaneous administration of 1 mg of subcutaneous Buserelin Acetate (Suprefact, Sanofi Aventis, Pakistan) in mid luteal phase of previous cycle.
Single-centre Bicalutamide 50 mg daily 153 during the first 4 weeks L, LA, & met Kawakami LHRH(a) (goserelin, leuprolide, 2013 (11) or buserelin) Single-centre 69 Met Dason 2013 (10) LHRH(a) (goserelin, leuprolide, Cohort series or triptorelin), 3-month depots 32 and a 1-month course of L, LA, & met bicalutamide on ADT initiation OR LHRH antagonist (degarelix), 1-month depots Study type/n/ T level setting Klotz [less than or equal to]0.7 nmol/l 2015 (8) RCT, (NT year 1; Multicentre n=489) 626 >0.7 to <1.7 Recurrent nmol/l (NT year 1; n=129) [greater than or equal to]1.7 nmol/l (NT year 1; n=8) Wang 2016 (12) [less than or equal to]0.9 nmol/l Single-centre (n=98) 206 Met >0.9 nmol/l (n=108) Bertaglia <0.7 nmol/l 2013 (9) (n=25)vs.
Taketani et al., "Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis-a randomized, double-blind, multicenter, controlled trial," Fertility and Sterility, vol.